undefined undefined
NaN.000
NaN.00%
Candel Therapeutics (NASDAQ:CADL) announced that the U.S. FDA has granted Orphan Drug Designation to CAN-2409, Candel’s most advanced multimodal biological immunotherapy candidate, for the treatment o...
04-11 21:18
Zai Lab (NASDAQ:ZLAB) said a confirmatory study for Bristol Myers’ (NYSE:BMY) drug Krazati has met its primary endpoint of progression-free survival in pretreated patients with KRASG12C-mutated locall...
04-01 22:57
Bristol Myers Squibb shares update on Phase 3 YELLOWSTONE trial for Zeposia (ozanimod) in Crohn's disease. Primary endpoint not met, safety consistent. Also, positive Phase 3 results for Krazati (adagrasib) in KRASG12C-mutated NSCLC.
04-01 21:44
Krystal Biotech's (NYSE:KRYS) short percent of float has risen 21.27% since its...
03-14 03:15
回顾2023年,医药行业经历了政策调整、一二级投融资环境艰难等多重挑战,这些影响不断考验着医药企业的创新增长和韧性发展。 对于投资者而言,要进一步判断各大药企的...
03-08 11:33
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
03-05 23:56
微策略周涨57%,比特币突破6万美元关口;高途周涨47%,Q4营收超预期;全球电动跑车第一股路特斯周跌42%>>
03-02 14:32
Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years...
02-29 23:30
Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday.
02-28 02:03